Lifecore Biomedical, Inc \de\ (LFCR) insider trading
Every open-market stock purchase and sale by Lifecore Biomedical, Inc \de\ executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Paul Josephs (CEO), $97.6K, 21 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent LFCR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 4, 2026 | Humberto Calheiros Antunes (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Paul Harold Johnson (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Lovas Katrina Houde (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Matthew E Korenberg (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Nelson Obus (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Joshua Schechter (Director) | Bought (not open market) | — |
| Jun 4, 2026 | Christopher S Kiper (10% owner) | Bought (not open market) | — |
| Jun 4, 2026 | Jason Aryeh (Director) | Bought (not open market) | — |
| May 20, 2026 | Paul Josephs (CEO) | Sold (not open market) | $185K |
| Apr 14, 2026 | Thomas D. Salus (Officer) | Sold (not open market) | $128K |
| Mar 2, 2026 | Thomas D. Salus (Officer) | Bought (not open market) | — |
Who's trading LFCR
- Paul Harold Johnson, Director: other filings, last Jun 4, 2026
- Jason Aryeh, Director: other filings, last Jun 4, 2026
- Joshua Schechter, Director: other filings, last Jun 4, 2026
- Nelson Obus, Director: other filings, last Jun 4, 2026
- Matthew E Korenberg, Director: other filings, last Jun 4, 2026
- Christopher S Kiper, 10% owner: other filings, last Jun 4, 2026
- Humberto Calheiros Antunes, Director: other filings, last Jun 4, 2026
- Lovas Katrina Houde, Director: other filings, last Jun 4, 2026
- Paul Josephs, CEO: other filings, last May 20, 2026
- Thomas D. Salus, Officer: other filings, last Apr 14, 2026
Get free alerts when an insider at Lifecore Biomedical, Inc \de\ files a new trade →